Amarin Corporation PLC (NASDAQ:AMRN)

3.10
Delayed Data
As of May 21
 -0.17 / -5.20%
Today’s Change
2.66
Today|||52-Week Range
4.60
-22.69%
Year-to-Date

Today’s Trading

Previous close3.27
Today’s open3.27
Day’s range3.08 - 3.30
Volume1,944,368
Average volume (3 months)2,227,423
Market cap$942.4M
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)+37.94%
Earnings growth (this year)-38.88%
Earnings growth (next 5 years)-249.00%
Revenue growth (last year)+41.69%
P/E ratioNM
Price/Sales5.93
Price/Book--

Competitors

----
RGNXRegenxbio Inc-2.30-4.72%
MEDPMedpace Holdings Inc-0.66-1.55%
CLXTCalyxt Inc+0.14+0.85%
Data as of 4:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$183.0M
Annual profit (last year)-$68.6M
Net profit margin-37.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts